<DOC>
	<DOCNO>NCT00161980</DOCNO>
	<brief_summary>This study monitor safety FS VH S/D evaluate whether FS VH S/D superior conventional surgical procedure reduction lymphatic leakage seal axillary lymphatics subject undergo lumpectomy level I II axillary lymph node dissection two separate incision .</brief_summary>
	<brief_title>Efficacy Safety Fibrin Sealant Vapor Heated Solvent/Detergent Treated ( FS VH S/D ) Reduction Lymphatic Leakage Sealing Axillary Lymph Node Dissection Sites</brief_title>
	<detailed_description />
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Written inform consent obtain subject prior FS VH S/D administration Female subject &gt; = 19 year age Subjects breast cancer schedule undergo lumpectomy breast level I II axillary lymphadenectomy two separate incision Subjects know hypersensitivity aprotinin component product Subjects immunodeficiency Subjects increase red cell production ( e.g. , hemolytic anemia ) Subjects coagulation disorder show exceed normal range follow : prothrombin time ( PT ) , Quick , activate partial thromboplastin time ( aPTT ) , fibrinogen level , thrombocyte . Subjects previously axillary surgery Subjects undergone irradiation therapy axillary tissue Subjects ever receive chemotherapy surgery</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Axillary wound</keyword>
	<keyword>Seroma</keyword>
	<keyword>Fistulae</keyword>
</DOC>